Presentation
17 March 2023 Transperineal laser ablation treatment for lower urinary tract symptoms in men: outcomes of a pilot study
Author Affiliations +
Proceedings Volume PC12353, Advanced Photonics in Urology 2023; PC1235304 (2023) https://doi.org/10.1117/12.2650309
Event: SPIE BiOS, 2023, San Francisco, California, United States
Abstract
Transperineal laser ablation (TPLA) is a novel minimal invasive treatment of benign prostatic obstruction. TPLA can be performed in an outpatient setting under local anesthesia with optional conscious sedation. The mechanism is based on laser ablation resulting in coagulative necrosis, which is induced by the laser light of 1064 nm. Laser light is delivered in the prostate trough transperineal placed needles. This study treated 20 men using TPLA to evaluate safety, feasibility, and voiding outcomes. TPLA has the potential to become an alternative for standard treatments with urethral approach that require general or spinal anesthesia and hospital admittance.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rob A. A. van Kollenburg, Luigi A. M. J. G. van Riel, Jorg R. Oddens, Theo M. de Reijke, Ton A. G. J. M. van Leeuwen, Harrie P. Beerlage, and Daniel M. de Bruin "Transperineal laser ablation treatment for lower urinary tract symptoms in men: outcomes of a pilot study", Proc. SPIE PC12353, Advanced Photonics in Urology 2023, PC1235304 (17 March 2023); https://doi.org/10.1117/12.2650309
Advertisement
Advertisement
KEYWORDS
Prostate

Laser ablation

Safety

Standards development

Surgery

Tissue optics

Back to Top